206 related articles for article (PubMed ID: 11356253)
1. Immunity to Rhodococcus equi: antigen-specific recall responses in the lungs of adult horses.
Hines MT; Paasch KM; Alperin DC; Palmer GH; Westhoff NC; Hines SA
Vet Immunol Immunopathol; 2001 May; 79(1-2):101-14. PubMed ID: 11356253
[TBL] [Abstract][Full Text] [Related]
2. Clearance of virulent but not avirulent Rhodococcus equi from the lungs of adult horses is associated with intracytoplasmic gamma interferon production by CD4+ and CD8+ T lymphocytes.
Hines SA; Stone DM; Hines MT; Alperin DC; Knowles DP; Norton LK; Hamilton MJ; Davis WC; McGuire TC
Clin Diagn Lab Immunol; 2003 Mar; 10(2):208-15. PubMed ID: 12626444
[TBL] [Abstract][Full Text] [Related]
3. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi.
Lopez AM; Hines MT; Palmer GH; Knowles DP; Alperin DC; Hines SA
Vaccine; 2003 Sep; 21(25-26):3815-25. PubMed ID: 12922115
[TBL] [Abstract][Full Text] [Related]
4. Identification of pulmonary T-lymphocyte and serum antibody isotype responses associated with protection against Rhodococcus equi.
Lopez AM; Hines MT; Palmer GH; Alperin DC; Hines SA
Clin Diagn Lab Immunol; 2002 Nov; 9(6):1270-6. PubMed ID: 12414760
[TBL] [Abstract][Full Text] [Related]
5. Rhodococcus equi secreted antigens are immunogenic and stimulate a type 1 recall response in the lungs of horses immune to R. equi infection.
Kohler AK; Stone DM; Hines MT; Byrne BA; Alperin DC; Norton LK; Hines SA
Infect Immun; 2003 Nov; 71(11):6329-37. PubMed ID: 14573652
[TBL] [Abstract][Full Text] [Related]
6. Use of Rhodococcus equi virulence-associated protein for immunization of foals against R equi pneumonia.
Prescott JF; Nicholson VM; Patterson MC; Zandona Meleiro MC; Caterino de Araujo A; Yager JA; Holmes MA
Am J Vet Res; 1997 Apr; 58(4):356-9. PubMed ID: 9099378
[TBL] [Abstract][Full Text] [Related]
7. Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction.
Jacks S; Giguère S; Crawford PC; Castleman WL
Clin Vaccine Immunol; 2007 Jun; 14(6):669-77. PubMed ID: 17409222
[TBL] [Abstract][Full Text] [Related]
8. Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals.
Patton KM; McGuire TC; Hines MT; Mealey RH; Hines SA
Infect Immun; 2005 Apr; 73(4):2083-93. PubMed ID: 15784549
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia.
Hooper-McGrevy KE; Giguere S; Wilkie BN; Prescott JF
Am J Vet Res; 2001 Aug; 62(8):1307-13. PubMed ID: 11497456
[TBL] [Abstract][Full Text] [Related]
10. Hematologic and immunophenotypic factors associated with development of Rhodococcus equi pneumonia of foals at equine breeding farms with endemic infection.
Chaffin MK; Cohen ND; Martens RJ; Edwards RF; Nevill M; Smith R
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):33-48. PubMed ID: 15182994
[TBL] [Abstract][Full Text] [Related]
11. VapA-specific IgG and IgG subclasses responses after natural infection and experimental challenge of foals with Rhodococcus equi.
Sanz MG; Villarino N; Ferreira-Oliveira A; Horohov DW
Vet Immunol Immunopathol; 2015 Mar; 164(1-2):10-5. PubMed ID: 25681111
[TBL] [Abstract][Full Text] [Related]
12. Use of a virulence-associated protein based enzyme-linked immunosorbent assay for Rhodococcus equi serology in horses.
Prescott JF; Fernandez AS; Nicholson VM; Patterson MC; Yager JA; Viel L; Perkins G
Equine Vet J; 1996 Sep; 28(5):344-9. PubMed ID: 8894530
[TBL] [Abstract][Full Text] [Related]
13. Failure of a VapA/CpG oligodeoxynucleotide vaccine to protect foals against experimental Rhocococcus equi pneumonia despite induction of VapA-specific antibody and interferon-γ response.
Lohmann KL; Lopez AM; Manning ST; Marques FJ; Brownlie R; Allen AL; Sangster AE; Mutwiri G; Gerdts V; Potter A; Townsend HG
Can J Vet Res; 2013 Jul; 77(3):161-9. PubMed ID: 24101791
[TBL] [Abstract][Full Text] [Related]
14. In vivo expression of and cell-mediated immune responses to the plasmid-encoded virulence-associated proteins of Rhodococcus equi in foals.
Jacks S; Giguère S; Prescott JF
Clin Vaccine Immunol; 2007 Apr; 14(4):369-74. PubMed ID: 17301216
[TBL] [Abstract][Full Text] [Related]
15. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine.
Cauchard J; Sevin C; Ballet JJ; Taouji S
Vet Microbiol; 2004 Nov; 104(1-2):73-81. PubMed ID: 15530741
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the immunogenic potential of Rhodococcus equi virulence associated protein (VapA) in mice.
Prescott JF; Patterson MC; Nicholson VM; Morein B; Yager JA
Vet Microbiol; 1997 Jun; 56(3-4):213-25. PubMed ID: 9226836
[TBL] [Abstract][Full Text] [Related]
17. Immunogenecity of synthetic peptides representing linear B-cell epitopes of VapA of Rhodococcus equi.
Taouji S; Nomura I; Giguère S; Tomomitsu S; Kakuda T; Ganne V; Takaï S
Vaccine; 2004 Mar; 22(9-10):1114-23. PubMed ID: 15003638
[TBL] [Abstract][Full Text] [Related]
18. Assessment in mice of vapA-DNA vaccination against Rhodococcus equi infection.
Haghighi HR; Prescott JF
Vet Immunol Immunopathol; 2005 Apr; 104(3-4):215-25. PubMed ID: 15734542
[TBL] [Abstract][Full Text] [Related]
19. Chimeric vapA/groEL2 DNA vaccines enhance clearance of Rhodococcus equi in aerosol challenged C3H/He mice.
Phumoonna T; Barton MD; Vanniasinkam T; Heuzenroeder MW
Vaccine; 2008 May; 26(20):2457-65. PubMed ID: 18423949
[TBL] [Abstract][Full Text] [Related]
20. Validation and evaluation of VapA-specific IgG and IgG subclass enzyme-linked immunosorbent assays (ELISAs) to identify foals with Rhodococcus equi pneumonia.
Sanz MG; Oliveira AF; Loynachan A; Page A; Svansson V; Giguère S; Horohov DW
Equine Vet J; 2016 Jan; 48(1):103-8. PubMed ID: 25257622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
